Valuation: Mayinglong Pharmaceutical Group Co., LTD.

Market Cap 985.82Cr 145.24Cr 126.97Cr 116.68Cr 108.76Cr 206.29Cr 14TCr 209.42Cr 1.4TCr 544.55Cr 6.8TCr 545.16Cr 533.45Cr 23TCr P/E 2026 *
14.7x
P/E 2027 * 12.2x
Enterprise Value 985.82Cr 145.24Cr 126.97Cr 116.68Cr 108.76Cr 206.29Cr 14TCr 209.42Cr 1.4TCr 544.55Cr 6.8TCr 545.16Cr 533.45Cr 23TCr EV / Sales 2026 *
2.28x
EV / Sales 2027 * 2.07x
Free-Float
64.65%
Yield 2026 *
-
Yield 2027 * -
1 day+1.19%
1 week+4.00%
Current month+5.78%
1 month-5.96%
3 months-11.01%
6 months-18.32%
Current year-18.32%
1 week 21.22
Extreme 21.22
23
1 month 21.22
Extreme 21.22
24.3
Current year 21.22
Extreme 21.22
29.22
1 year 21.22
Extreme 21.22
30.18
3 years 20.2
Extreme 20.2
31.46
5 years 17.99
Extreme 17.99
33.34
10 years 12.52
Extreme 12.52
33.54
Manager TitleAgeSince
Chief Executive Officer 48 28/05/2019
Director of Finance/CFO 49 28/12/2023
Corporate Officer/Principal 40 19/08/2021
Director TitleAgeSince
Chairman 64 16/03/2010
Director/Board Member 48 28/05/2019
Director/Board Member 40 14/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
+1.19%+4.00%-17.70%-17.76% 143.42Cr
+3.45%+7.65%+55.77%+158.84% 1,08200Cr
-1.16%+7.42%+69.09%+58.92% 63TCr
-0.77%+7.37%+36.87%+93.77% 46TCr
-0.35%+1.85%+31.30%+24.86% 34TCr
-0.56%+0.96%+41.67%+39.35% 30TCr
-0.08%+1.30%+32.15%+44.48% 29TCr
-1.54%+2.81%-25.35%-39.61% 23TCr
+3.55%+6.05%+26.04%+68.52% 20TCr
+0.40%+6.00%+17.72%+70.33% 16TCr
Average +1.09%+4.70%+26.76%+50.17% 37.01TCr
Weighted average by Cap. +1.04%+5.54%+42.18%+81.64%

Financials

2026 *2027 *
Net sales 431.8Cr 64Cr 56Cr 51Cr 48Cr 90Cr 6.06TCr 92Cr 613.56Cr 238.52Cr 2.98TCr 238.79Cr 233.66Cr 10TCr 475.4Cr 70Cr 61Cr 56Cr 52Cr 99Cr 6.67TCr 100.99Cr 675.51Cr 262.6Cr 3.28TCr 262.9Cr 257.25Cr 11TCr
Net income 67Cr 9.93Cr 8.68Cr 7.98Cr 7.44Cr 14Cr 945.45Cr 14Cr 96Cr 37Cr 464.74Cr 37Cr 36Cr 1.6TCr 74Cr 11Cr 9.59Cr 8.82Cr 8.22Cr 16Cr 1.05TCr 16Cr 105.86Cr 41Cr 513.7Cr 41Cr 40Cr 1.77TCr
Net Debt - -
Logo Mayinglong Pharmaceutical Group Co., LTD.
Mayinglong Pharmaceutical Group Co Ltd is a China-based company mainly engaged in the production and sale of anorectal health products. The Company operates three segments. The Pharmaceutical Industry segment is mainly engaged in the development, production and sale of pharmaceuticals and health products. The Pharmaceutical Commerce segment is mainly engaged in the retail and wholesale of medical devices and pharmaceuticals. The Hospital Diagnosis and Treatment segment is mainly engaged in hospital medical services and management. The Company mainly conducts businesses within the domestic market.
Employees
2,544
Date Price Change Volume
03/26/03 CN¥22.87 +1.19% 41,68,745
02/26/02 CN¥22.60 +1.62% 49,69,360
01/26/01 CN¥22.24 +2.87% 49,20,490
30/26/30 CN¥21.62 -2.92% 48,86,673
29/26/29 CN¥22.27 +3.34% 62,54,597
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
22.87CNY
Average target price
36.25CNY
Spread / Average Target
+58.50%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600993 Stock